Skip to main content
. 2022 Jan 13;14(1):e21219. doi: 10.7759/cureus.21219

Table 2. Percentage of patients reporting a minimal clinically important difference (MCID) and remission at endline.

PHQ-9: Patient Health Questionnaire-9; TAU: treatment as usual

  TAU (n=710)   Brightside (n=5571)  
  % N % N
Percentage of patients achieving MCID as per PHQ-9 (5+ reduction) 52.0 369 79.2 4412
Percentage of patients achieving remission (score <10) as per PHQ-9 39.6 281 59.8 3332